Covered recipient · General Payments record
ARIE L WEINSTOCK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$27,841.92
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,674.00 | 1 |
| Food and Beverage | $787.01 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otter Pharmaceuticals, LLC | $1,674.00 | 1 |
| Pyros Pharmaceuticals, Inc. | $195.32 | 2 |
| Neurelis, Inc. | $168.87 | 2 |
| NEUROPACE, INC. | $137.49 | 1 |
| UCB, Inc. | $92.26 | 4 |
| BIOCODEX, INC. | $84.74 | 1 |
| JAZZ PHARMACEUTICALS INC. | $45.83 | 1 |
| LivaNova USA, Inc. | $41.66 | 2 |
| ACADIA Pharmaceuticals Inc | $20.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $20.84 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147997235 | CMS |
| BIOCODEX, INC. | $84.74 | 12/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146420768 | CMS |
| JAZZ PHARMACEUTICALS INC. | $45.83 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150239534 | CMS |
| LivaNova USA, Inc. | $18.69 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152795645 | CMS |
| LivaNova USA, Inc. | $22.97 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152795647 | CMS |
| Neurelis, Inc. | $145.71 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145658269 | CMS |
| Neurelis, Inc. | $23.16 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145658271 | CMS |
| NEUROPACE, INC. | $137.49 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153275472 | CMS |
| Otter Pharmaceuticals, LLC | $1,674.00 | 11/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148637998 | CMS |
| Pyros Pharmaceuticals, Inc. | $189.56 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145043574 | CMS |
| Pyros Pharmaceuticals, Inc. | $5.76 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145043576 | CMS |
| UCB, Inc. | $16.84 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469328 | CMS |
| UCB, Inc. | $15.76 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469332 | CMS |
| UCB, Inc. | $28.45 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469336 | CMS |
| UCB, Inc. | $31.21 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469340 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.